| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Scynexis Inc (SCYX) has 7 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. SCYX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 853.1K | $3.28M | - | |
| Dir | 78.0K | $299.9K | - | |
| Dir | 74.0K | $284.5K | - | |
| Dir | 70.0K | $269.1K | - | |
| Dir | 69.6K | $267.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 23, 2017 | Taglietti Marco | Chief Executive Officer | Buy | 5,000 | $1.85 | $9,248.32 | +0.9% | |
| Aug 15, 2017 | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $1.61 | $16,100.00 | +3.6% | |
| Aug 11, 2017 | Angulo Gonzalez David | Chief Medical Officer | Buy | 10,000 | $1.55 | $15,500.00 | +16.1% | |
| Jun 21, 2017 | Hastings David C | Director | Buy | 20,000 | $1.75 | $35,000.00 | New | |
| May 12, 2017 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.69 | $42,250.00 | +9.9% | |
| May 12, 2017 | Angulo Gonzalez David | Chief Medical Officer | Buy | 15,000 | $1.70 | $25,500.00 | +31.9% | |
| Dec 21, 2016 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $3.30 | $82,500.00 | +11.1% | |
| Dec 16, 2016 | Angulo Gonzalez David | Chief Medical Officer | Buy | 4,000 | $3.25 | $13,000.00 | +9.5% | |
| Sep 15, 2016 | MacHado Patrick | Director | Buy | 40,000 | $2.94 | $117,600.00 | +200.0% | |
| Jun 30, 2016 | Angulo Gonzalez David | Chief Medical Officer | Buy | 36,950 | $2.22 | $82,158.50 | +286.4% |